The Kings Fund has published ‘Map of technology and data in health and care’.
This interactive map brings together case studies from across England and the rest of world, highlighting some of the places that are experimenting with and implementing new technologies to achieve better health outcomes or more efficient care.
The map is not a comprehensive listing of all such projects – it is limited to case studies featured in The King’s Fund publications and events, plus the NHS test bed sites set up to evaluate the real-world impact of new technologies.
While most people will agree that excessive consumption of alcohol can have a detrimental effect on the brain, there is less agreement regarding the effects of light or moderate drinking. This includes concern and controversy surrounding the effects of drinking on the development of neurodegenerative diseases such as Alzheimer’s (AD). This study investigated the association between consumption of different alcoholic beverages — beer, wine, and spirits — and one of the neuropathological signs of Alzheimer’s disease, β-amyloid (Aβ) aggregation in the brain.
Researchers examined data from 125 males participating in the Helsinki sudden death autopsy series, who at the time of death were 35 to 70 years old. Consumption of alcohol, Aβ aggregation in the brain, and apolipoprotein E (APOE) genotype were assessed. Surviving relatives answered a questionnaire used to gather the drinking history of the deceased, and Aβ was observed by immunohistochemical staining of brain sections.
A Google Scholar search using the term “evidence based medicine” identifies more than 1.8 million papers. Over more than two decades, evidence based medicine has rightfully become part of the fabric of modern clinical practice and has contributed to many advances in healthcare.
But many clinicians and patients have expressed dissatisfaction with the way evidence based medicine has been applied to individuals, especially in primary care.1 There is concern that guidelines intended to reduce variation and improve the quality of care have instead resulted in medicine becoming authoritarian and bureaucratic.2 Evidence generated from large populations has been distilled into large numbers of lengthy and technically complex guidelines. Guidelines in turn have been used to create financial incentive schemes such as the UK’s Quality and Outcomes Framework, whereby a substantial proportion of general practice income depends on achieving thresholds for drug therapy or surrogate outcomes in accordance with National Institute for Health and Care Excellence guidelines. Not only do these thresholds exceed the limits of the evidence for many people but they also encourage clinicians to ignore the need to elicit and respect the preferences and goals of patients.
Julian Treadwell, Neal Maskrey and Richard Lehman join us in the studio to argue that new models of evidence synthesis and shared decision making are needed to accelerate a move from guideline driven care to individualised care.
Dementia Rarely Travels Alone: living with dementia and other conditions | Alzheimers Society
A report on the All Party Parliamentary Group on Dementia’s inquiry that was held last year in to dementia and comorbidities. The inquiry has brought to light the scale of difficulty faced by people living with dementia and other health conditions.
Despite significant progress to deliver integrated care services and support, the health and social system frequently treats conditions in isolation so that people with dementia and other health conditions receive disjointed, substandard care and treatment.
The report identifies the changes needed across the healthcare system so that the NHS can meet the challenge of caring for people living with dementia and other conditions, supporting them to live fulfilled lives and makes recommendations as to how this can be achieved.
This statistical report presents a range of information on smoking which is drawn together from a variety of sources. The report aims to present a broad picture of health issues relating to smoking in England and covers topics such as smoking prevalence, habits, behaviours and attitudes among adults and school children, smoking-related ill health and mortality and smoking-related costs.
The topics covered include:
Part 1: Smoking patterns in adults
Part 2: Smoking patterns in children
Part 3: Availability and affordability of tobacco
Part 4: Behaviour and attitudes to smoking
Part 5: Smoking-related costs, ill health and mortality
Each part provides an overview of the key findings on these topics, as well as providing links to sources of further information and relevant documents.
This report highlights the important role app and wearable technology will play in healthcare. It finds that the emergence of wearable and app technology in healthcare presents policymakers with an unprecedented opportunity to engage patients in their own healthcare. It concludes that, if care teams had access to user-generated data, it could enrich their understanding of the patient and how best to manage their condition.